Drug-Induced Intracranial Hypertension: A Systematic Review and Critical Assessment of Drug-Induced Causes.
Tan MG, Worley B, Kim WB, Ten Hove M, Beecker J.
Am J Clin Dermatol. 2020 Apr;21(2):163-172. doi: 10.1007/s40257-019-00485-z.
Drug-induced liver injury in obesity and nonalcoholic fatty liver disease.
Allard J, Le Guillou D, Begriche K, Fromenty B.
Adv Pharmacol. 2019;85:75-107. doi: 10.1016/bs.apha.2019.01.003. Epub 2019 Feb 20.
A Review on Drug Induced Obesity and Rodent Experimental Models of Obesity in Animals.
Vangoori Y, Suresh BS, Midde ML, Anusha D, Uppala PK.
Maedica (Bucur). 2022 Sep;17(3):706-713. doi: 10.26574/maedica.2022.17.3.706.
Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.
Verhaegen AA, Van Gaal LF.
J Endocrinol Invest. 2017 Nov;40(11):1165-1174. doi: 10.1007/s40618-017-0719-6. Epub 2017 Jun 28.
Drug-induced liver injury in obesity.
Fromenty B.
J Hepatol. 2013 Apr;58(4):824-6. doi: 10.1016/j.jhep.2012.12.018. Epub 2013 Jan 5.
Decreased 5-HT2cR and GHSR1a interaction in antipsychotic drug-induced obesity.
Huang XF, Weston-Green K, Yu Y.
Obes Rev. 2018 Mar;19(3):396-405. doi: 10.1111/obr.12638. Epub 2017 Nov 9.
Drug-Induced Mitochondrial Toxicity.
Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJ.
Drug Saf. 2016 Jul;39(7):661-74. doi: 10.1007/s40264-016-0417-x.
Drug-Induced Sleep Endoscopy Findings in Children With Obstructive Sleep Apnea With vs Without Obesity or Down Syndrome.
Hyzer JM, Milczuk HA, Macarthur CJ, King EF, Quintanilla-Dieck L, Lam DJ.
JAMA Otolaryngol Head Neck Surg. 2021 Feb 1;147(2):175-181. doi: 10.1001/jamaoto.2020.4548.
Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders.
Zhao S, Lin Q, Xiong W, Li L, Straub L, Zhang D, Zapata R, Zhu Q, Sun XN, Zhang Z, Funcke JB, Li C, Chen S, Zhu Y, Jiang N, Li G, Xu Z, Wyler SC, Wang MY, Bai J, Han X, Kusminski CM, Zhang N, An Z, Elmquist JK, Osborn O, Liu C, Scherer PE.
Sci Transl Med. 2023 Nov 22;15(723):eade8460. doi: 10.1126/scitranslmed.ade8460. Epub 2023 Nov 22.
Obesity Potentiates the Risk of Drug-Induced Long QT Syndrome - Preliminary Evidence from WNIN/Ob Spontaneously Obese Rat.
Potnuri AG, Reddy KP, Suresh P, Husain GM, Kazmi MH, Harishankar N.
Cardiovasc Toxicol. 2021 Oct;21(10):848-858. doi: 10.1007/s12012-021-09675-w. Epub 2021 Jul 24.
